On Tuesday, Tandem Diabetes Care Inc (NASDAQ: TNDM) was 3.99% jump from the session before ,before settling in for the closing price of $33.55. A 52-week range for TNDM has been $13.82 – $43.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 36.59% over the last five years. When this article was written, the company’s average yearly earnings per share was at 50.89%. With a float of $65.19 million, this company’s outstanding shares have now reached $65.55 million.
The firm has a total of 2400 workers. Let’s measure their productivity.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tandem Diabetes Care Inc stocks. The insider ownership of Tandem Diabetes Care Inc is 0.68%, while institutional ownership is 109.00%. The most recent insider transaction that took place on Nov 27 ’23, was worth 94,778. In this transaction Director of this company bought 5,000 shares at a rate of $18.96, taking the stock ownership to the 19,962 shares. Before that another transaction happened on Nov 08 ’23, when Company’s EVP & CHIEF FINANCIAL OFFICER bought 6,200 for $15.39, making the entire transaction worth $95,395. This insider now owns 11,860 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted -$0.27 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.25) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.89% per share during the next fiscal year.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
You can see what Tandem Diabetes Care Inc (TNDM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.44, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Analysing the last 5-days average volume posted by the [Tandem Diabetes Care Inc, TNDM], we can find that recorded value of 1.1 million was lower than the volume posted last year of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 57.95%. Additionally, its Average True Range was 1.82.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 94.09%, which indicates a significant increase from 80.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.85% in the past 14 days, which was lower than the 73.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.19, while its 200-day Moving Average is $25.31. Now, the first resistance to watch is $35.55. This is followed by the second major resistance level at $36.22. The third major resistance level sits at $37.20. If the price goes on to break the first support level at $33.90, it is likely to go to the next support level at $32.92. Now, if the price goes above the second support level, the third support stands at $32.25.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are 65,631K outstanding shares of the company, which has a market capitalization of 2.29 billion. As of now, sales total 747,720 K while income totals -222,610 K. Its latest quarter income was 196,800 K while its last quarter net income were -30,000 K.
